Association between model for end-stage liver disease and spontaneous bacterial peritonitis

American Journal of Gastroenterology

Volumn 102, Issue 12, 2007, Pages 2732-2736

  Obstein, Keith L ^a   Campbell, Mical S ^a   Reddy, K Rajender ^a   Yang, Yu Xiao ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PARACENTESIS; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SODIUM BLOOD LEVEL; SPONTANEOUS BACTERIAL PERITONITIS; STATISTICAL PARAMETERS;

ASCITES; CASE-CONTROL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LOGISTIC MODELS; MALE; MIDDLE AGED; PENNSYLVANIA; PERITONITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TIME FACTORS;

EID: 36549036676     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01485.x     Document Type: Article

References (24)

1. Pinzello G, Simonetti RG, Craxi A, et al. Spontaneous bacterial peritonitis: A prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1993 3 : 545 9.
2. Runyon BA, Squier SU, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994 21 : 792 6.
3. Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001 34 : 32 7.
4. Garcia-Tsao G, Albillos A, Barden GE, et al. Bacterial translocation in acute and chronic portal hypertension. Hepatology 1993 17 : 1081 5.
5. Llovet JM, Bartoli R, March F, et al. Translocated intestinal bacterial cause spontaneous bacterial peritonitis in cirrhotic rats: Molecular epidemiologic evidence. J Hepatol 1998 28 : 307 13.
6. Guarner C, Runyon BA, Youns S, et al. Intestinal bacterial overgrowth and bacterial translocation in an experimental model of cirrhosis in rats. J Hepatol 1997 26 : 1372 8.
7. Fiuza C, Salcedo M, Clemente G, et al. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000 182 : 526 33.
8. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988 8 : 632 5.
9. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis-In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 2001 96 : 1232 6.
10. Llovet JM, Planas R, Morillas R, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: Multivariate study. Am J Gastroenterol 1993 88 : 388 92.
11. Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993 17 : 251 7.
12. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999 341 : 403 9.
13. Runyon BA, McHutchinson JG, Antillon MR, et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: A randomized controlled study of 100 patients. Gastroenterology 1991 100 : 1737 42.
14. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 33 : 464 70.
15. Huo TI, Wu JC, Lin HC, et al. Evaluation of the increase in Model for End-stage Liver Disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: Risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005 42 : 826 32.
16. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989 129 : 125 37.
17. Wiesner R, Edwards E, Freeman R, et al. The United Network For Organ Sharing Liver Disease Severity Score Committee. Model for End-stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003 124 : 91.
18. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: A European study. Gut 2003 52 : 134.
19. Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006 20 : 188 94.
20. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998 27 : 669 74.
21. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med 1986 146 : 2259 61.
22. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006 130 : 1652 60.
23. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005 41 : 32 9.
24. Heuman DM, Abou-assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004 40 : 802 10.